UK NSC moves to 2-yearly open call cycle
UK NSC moves to 2-yearly open call cycle
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
We take a look back at a successful and busy first year for the UK NSC research and methodology group.
Dr Jessica Lloyd and Dr Sowmiya Moorthie, of Cancer Research UK, discuss multi-cancer tests, their potential use in screening, their challenges and uncertainties.
Profile on Professor Natalie Armstrong, the UK NSC’s implementation scientist expert
Routine antenatal screening and neonatal immunisation have helped England achieve the World Health Organisation elimination targets for hepatitis B mother to child transmission.
The latest meeting of the SMA Screening In-service evaluation Partnership Board heard that significant progress had been made with the planning of the newborn screening ISE for spinal muscular atrophy.
Profile of UK NSC test expert member Professor Bethany Shinkins.
Today we have published the UK NSC annual report, summarising the committee’s work and achievements during the year 1 April 2023 to 31 March 2024
The UK NSC is working to understand multi-cancer detection tests and their possible impact on screening through multiple strands of work.
An update from the third meeting of the spinal muscular atrophy screening in-service evaluation partnership board.
Two new dates have been announced for our popular screening masterclasses in autumn 2024.